Drug Industry Daily
Feb. 27, 2008
| Vol.
7 No.
40
Federal Jury Awards $2.75 Million in Hormone Replacement Therapy Case
Wyeth and Pfizer failed to warn patients that use of their hormone replacement therapies Premarin, Prempro and Provera could potentially cause breast cancer, contributing to the development of the condition by an Arkansas woman, a federal jury has found.
This article is viewable by subscribers only. To view this article, please select an option below.
|